Experimental Rx May Cure Hepatitis C in Six Weeks
Achillion Pharmaceuticals Inc. announced today that its experimental hepatitis C treatment may be able to reverse hepatitis C in as little as six weeks.
This Hep C Rx Combo May Be Quicker Cure
For people with hepatitis C, three isn't a crowd. These patients got well much faster with the addition of a third medication.
Cirrhosis: Usually Preventable but Common
Cirrhosis of the liver may usually be preventable, but it may be more common than previously thought. Fortunately, patients can take simple steps to keep their livers in tip-top shape.
FDA Approves New Combo Treatment for Hep C
In recent years, people with hepatitis C have gained several new treatment options. The US Food and Drug Administration (FDA) has added another option to the list.
Hepatitis C Patients May Live Longer With Treatment
For patients with chronic hepatitis C, liver problems can sometimes shorten their lives. But a new study found that successful treatment might ease some life expectancy concerns for these patients.
FDA Approves Combo Treatment for Hepatitis C
The US Food and Drug Administration (FDA) approved a new combination treatment for hepatitis C infection Wednesday.
FDA Approves New Combo Rx for Hepatitis C
US regulators have approved a new pill to treat hepatitis C. That pill, which is a combination of two medications, could simplify treatment for patients.
International Attention Given to Hepatitis
Having treatment options for a condition is great, but it isn't much help when people don't realize they are ill. This is often the case with hepatitis, say experts trying to raise awareness of the condition through World Hepatitis Day.
Dual Therapy May Control Hepatitis C in HIV Patients
For patients with human immunodeficiency virus (HIV), hepatitis C (HCV) can also be a problem. A new combination of medications, however, may effectively treat HCV in those with HIV.
USPSTF Issues Updated Hepatitis B Screening Guidelines
While there is no cure for hepatitis B, doctors can treat infected patients to prevent serious complications. But first, these doctors need to know who is infected, which is why experts recently updated screening guidelines for hepatitis B.